- Report
- March 2022
- 198 Pages
Global
From €3941EUR$4,450USD£3,417GBP
- Report
- July 2024
- 120 Pages
Global
From €4207EUR$4,750USD£3,647GBP
- Report
- February 2024
- 116 Pages
Global
From €4207EUR$4,750USD£3,647GBP
- Report
- August 2022
- 105 Pages
Global
From €4207EUR$4,750USD£3,647GBP
- Report
- May 2024
- 130 Pages
Global
From €2799EUR$3,160USD£2,426GBP
€3498EUR$3,950USD£3,033GBP
- Report
- February 2024
- 115 Pages
Global
From €4207EUR$4,750USD£3,647GBP
- Report
- June 2025
- 250 Pages
India
From €2470EUR$2,789USD£2,141GBP
- Report
- December 2023
- 160 Pages
United States
From €2470EUR$2,789USD£2,141GBP
- Report
- May 2023
- 147 Pages
Global
From €4383EUR$4,949USD£3,800GBP
- Report
- July 2024
- 90 Pages
China
From €1594EUR$1,800USD£1,382GBP
- Report
- July 2024
- 326 Pages
China
From €3542EUR$4,000USD£3,071GBP
- Report
- September 2023
- 114 Pages
Global
From €2613EUR$2,950USD£2,265GBP
- Report
- September 2023
- 87 Pages
Africa, Middle East
From €2613EUR$2,950USD£2,265GBP
- Report
- September 2023
- 89 Pages
From €2613EUR$2,950USD£2,265GBP
- Report
- September 2023
- 107 Pages
Asia Pacific
From €3055EUR$3,450USD£2,649GBP
- Report
- September 2023
- 112 Pages
Europe
From €3055EUR$3,450USD£2,649GBP
- Report
- September 2023
- 101 Pages
North America
From €2613EUR$2,950USD£2,265GBP
- Report
- September 2023
- 194 Pages
Global
From €4384EUR$4,950USD£3,801GBP
- Report
- October 2024
- 78 Pages
Global
From €3500EUR$4,234USD£3,141GBP
- Report
- October 2024
- 103 Pages
Global
From €3500EUR$4,234USD£3,141GBP

Toxoid vaccines are a type of vaccine that use a modified form of a toxin or toxin-producing microorganism to stimulate the body's immune system to produce antibodies against the toxin. The toxin is usually inactivated or weakened so that it does not cause disease, but still stimulates the body's immune system to produce antibodies. Toxoid vaccines are used to protect against a variety of diseases, including diphtheria, tetanus, and pertussis.
Toxoid vaccines are widely used in both developed and developing countries, and are an important part of routine immunization programs. They are also used in the prevention of certain occupational diseases, such as tetanus in healthcare workers.
The toxoid vaccine market is highly competitive, with a number of companies offering a range of products. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more